PharmiWeb.com - Global Pharma News & Resources

Press Releases

Date Title Company
08-Jan-2024 Cell and Gene Therapy Catapult announces successful renewal of its five-year funding from Innovate UK to further support the advanced therapies sector The Cell and Gene Therapy Catapult
08-Jan-2024 Kelso Pharma closes acquisition of Italian specialty pharma company, Velit Biopharma Kelso Pharma
08-Jan-2024 BIOS Health Plans State-of-the-Art Precision Medicine Center in Bakersfield, California Kern Venture Groupv
08-Jan-2024 Nobel Prize-winning tagging system used to map a new class of drug targets in cancer and immunology Imperial College London 
08-Jan-2024 FluoGuide Provides Strategic Update and Outlines Development Plans Towards Commercialization of FG001 AccessWire
08-Jan-2024 Type 2 Diabetes Market: Analysis Of Epidemiology, Industry Trends, Size, Share, And Future Forecast (2023-2033) IMARC Group
08-Jan-2024 Eckert & Ziegler and ARTBIO Announce Manufacturing and Supply Partnership for Lead-212 Conjugates Eckert & Ziegler Strahlen- und Medizintechnik AG
08-Jan-2024 Emerging Opportunities in the Tissue Engineering Market: A Holistic Market Study Markets and Markets
08-Jan-2024 MorphoSys to Present at the 42nd Annual J.P. Morgan Healthcare Conference AccessWire
08-Jan-2024 Occlutech(R) Announces FDA Approval of its Occlutech(R) ASD Occluder and Occlutech(R) Pistol Pusher, a Minimally Invasive Cardiac Device and Delivery System to Treat Atrial Septal Defects AccessWire
08-Jan-2024 MorphoSys to Present at the 42nd Annual J.P. Morgan Healthcare Conference  MorphoSys AG
08-Jan-2024 Calypso Enters into Agreement to Be Acquired by Novartis B3C newswire
08-Jan-2024 Hemogenyx Pharmaceuticals PLC Announces HEMO-CAR-T Process Qualification Run Completed AccessWire
08-Jan-2024 Evotec announces progress in strategic neuroscience partnership with Bristol Myers Squibb Evotec SE
08-Jan-2024 Revolutionizing Healthcare: Medical Waste Management Market Projected to Reach USD 12.83 billion by 2030 at a 5.8% CAGR The Wire Times
08-Jan-2024 Revolutionizing Healthcare: Gene Therapy Market Projected to Reach USD 46.5 billion by 2030 at a 22.8% CAGR The Wire Times
05-Jan-2024 Jaguar Health Announces New Employee Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) AccessWire
05-Jan-2024 Tiziana Life Sciences to Present at Biotech Showcase Conference in San Francisco, January 8-10, 2024 Tiziana Life Sciences Ltd
05-Jan-2024 HI-Bio Announces $95 Million Series B Financing to Advance Targeted Therapies for Immune-Mediated Diseases Human Immunology Biosciences
05-Jan-2024 LAUSANNE, Switzerland, Jan. 04, 2024 (GLOBE NEWSWIRE) -- ADC Therapeutics SA (NYSE: ADCT) today announced that it received a notice from the New York Stock Exchange (NYSE) on January 2, 2024 that the Company has regained compliance with the continued listing minimum price criteria set forth in Section 802.01C of the NYSE Listed Company Manual and, as a result, will be removed from the NYSE’s noncompliant issuers list. The Company previously received a notice from the NYSE that it was not in comp ADC Therapeutics